
Arcutis Biotherapeutics Inc
ARQTNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$21.45
Day High
$21.59
Day Low
$21.09
Prev. Close
$21.44
VolumeShares traded today.
1.52M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$2.68B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-1021.90
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$31.77
52W LowLowest price over the past 52 weeks.
$12.72
50D MAAverage closing price over the last 50 trading days.
$22.62
200D MAAverage closing price over the last 200 trading days.
$23.47
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+2.1%1M
-4.1%6M
-30.2%YTD
-26.0%1Y
+59.2%About
A phosphodiesterase-4 inhibitor, commonly referred to as a PDE4 inhibitor, is a drug used to block the degradative action of phosphodiesterase 4 (PDE4) on cyclic adenosine monophosphate (cAMP). It is a member of the larger family of PDE inhibitors. The PDE4 family of enzymes are the most prevalent PDE in immune cells. They are predominantly responsible for hydrolyzing cAMP within both immune cells and cells in the central nervous system.
arcutis.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade ARQT
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.